Monoclonal gammopathy of unknown significance and malignant paraproteinemia in Hong Kong

American Journal of Clinical Pathology

Volumn 106, Issue 4, 1996, Pages 449-456

  Lolin, Yvette I ^a   Chow, John ^a   Wickham, Nicholas W R ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Hong Kong; Lymphoma; MGUS; Myeloma; Paraproteinemia

Indexed keywords

BENCE JONES PROTEIN; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LAMBDA CHAIN; POLYCLONAL ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; FEMALE; HONG KONG; HUMAN; HYPOGAMMAGLOBULINEMIA; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; PARAPROTEINEMIA; PRIORITY JOURNAL; T CELL LEUKEMIA; T CELL LYMPHOMA;

EID: 0029762496     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/106.4.449     Document Type: Article

References (42)

1. Riedel DA, Pottem LM. The epidemiology of multiple myeloma. Hem Oncol Clin North Am 1992;6:225-247.
2. Wang CR, Chuang CY, Lin KT, et al. Monoclonal gammopathies and related autoimmune manifestations in Taiwan. Asian Pac J Allergy Immunol 1992;10:123-128.
3. Axelsson U, Bachmann R, Hallen J. Frequency of pathological proteins (M-component) in 6,995 sera from an adult population. Acta Med Scand 1966;179:235-247.
4. Hobbs JR. Immunoglobulins in clinical chemistry. Adv Clin Chem 1971;14:218-317.
5. Conklin R, Alexanian R. Clinical classification of plasma cell myeloma. Arch Intern Med 1975;135:139-143.
6. Hobbs JR. Monitoring immunocytoma. Minerva Med 1978;69: 2499-2506.
7. Malacrida V, De Francesco D, Banfi G, Porta FA, Riches PG. Laboratory investigation of monoclonal gammopathy during 10 years of screening in a general hospital. J Clin Pathol 1987;40: 793-797.
8. Bowden M, Crawford J, Cohen HJ, Noyama O. A comparative study of monoclonal gammopathies and immunoglobulin levels in Japanese and United States elderly. J Am Geriatr Soc 1993;41:11-14.
9. Nilsson T, Norberg B, Rudolphi O, Jacobsson L. Double gammopathy: Incidence and clinical course in 20 patients. Scand J Haematol 1986;36:103-106.
10. Damacco F, Waldenstrom J. Bence Jones proteinuria in benign monoclonal gammopathies: incidence and characteristics. Acta Med Scand 1969;184:403-409.
11. Peltonen S, Wassatjerna C, Wagner O. Clinical features of patients with a serum M component. Acta Med Scand 1978;203:257-263.
12. Hobbs JR. Paraproteins, benign or malignant. BMJ 1967;3:699-704.
13. Kyle RA. Monoclonal gammopathy of undetermined significance. Blood Rev 1994;8:135-142.
14. Kyle RA, Lust JA. Monoclonal gammopathies of undetermined significance. Sem Hematol 1989;26:176-200.
15. Kyle RA, Lust JA. The monoclonal gammopathies (paraproteins). Adv Clin Chem 1990;28:145-218.
16. Kyle RA, Robinson RA, Katzman JA. The clinical aspects of biclonal gammopathies: Review of 57 cases. Am J Med 1981;71: 999-1008.
17. Whicher JT, Calvin J, Riches P, Warren C. The laboratory investigation of paraproteinaemia, Ann Clin Biochem 1987;24:119-132.
18. Lei KIK, Chow J, Johnson PJ. Aggressive primary hepatic lymphoma in Chinese patients. Cancer 1995;76:1336-1346.
19. Paraproteinaemia [Editorial]. BMJ 1980;280:273-274.
20. Cancer Registry of the Hong Kong Government Medical and Health Department, Institute of Radiology and Oncology, 1991.
21. Ng CS, Chan JKC, Lo STH, Poon YF. Immunophenotypic analysis of non-Hodgkin's lymphomas in Chinese. A study of 75 cases in Hong Kong. Pathology 1986;18:419-425.
22. Shin LY, Liang DC. Non-Hodgkin's lymphomas in Asia. Hem Oncol Clin North Am, 1991;5:983-1001.
23. Yoshida M, Seiki M, Yamaguchi K, Takatsuki K. Monoclonal integration of human T-cell leukaemia provirus in all primary tumours of adult T-cell leukaemia suggests causative role of human T-cell leukaemia virus in the disease. Proc Natl Acad Sci USA 1984;81:2534-2537.
24. Jones JF, Schurin S, Abramowsky C, et al. T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections. N Engl J Med 1988;318:733-741.
25. Zhou XG, Hamilton-Dutoit SJ, Yan QH, Pallesen G. High frequency of Epstein-Barr virus in Chinese peripheral T-cell lymphoma. Histopathology 1994;24:115-122.
26. Knecht H. Angioimmunoblastic lymphadenopathy: Ten years' experience and state of knowledge. Sem Hematol 1989;26:208-215.
27. Venencie PY, Winkelmann RK, Puissant A, Kyle RA. Monoclonal gammopathy in Sezary syndrome: Report of three cases and review of the literature. Arch Dermatol 1984;120:605-608.
28. Kamihira S, Taguchi H, Kinoshita K, Ichimaru M. Monoclonal gammopathy in adult T-cell leukaemia/lymphoma: A report of three cases. Jpn J Clin Oncol 1984;14:699-704.
29. Matsuzaki H, Yamaguchi K, Kagimoto T, et al. Monoclonal gammopathies in adult T-cell leukaemia. Cancer 1985;56:1380-1383.
30. Kasajima T, Masuda A, Matsuda M, Imai Y, Tobinai K. IBL-like T-cell lymphoma expressing monoclonal gammopathy (macroglobulinaemia). Histol Histopathol 1989;4:271-279.
31. Kornstein MJ, deBlois GC, Williams ME. Unusual biclonal plasma cell dyscrasia with crystallike inclusions producing coIonic tumours (plasma cell polyposis) and terminating in T-cell lymphoma. Arch Pathol Lab Med 1992;116:168-172.
32. Kohler M, Daus H, Kohler C, Schlimmer P, Wernert N, Scheurlen PG. Lymphocytic plasmacytoid lymphoma with a three-banded gammopathy: Reactivity of one of these paraproteins with cytomegalovirus. Blut 1987;54:25-32.
33. Murata T, Fujita H, Harano H, et al. Triclonal gammopathy (IgAk, IgGk, and IgMk) in a patient with plasmacytoid lymphoma-derived from a monoclonal origin. Am J Hematol 1993;42:212-216.
34. Ward AM. Proteinuria including protein clearance ratios. In: Ward AM, ed. SAS Protein Reference Units: Handbook of Clinical Immunochemistry, 1990, pp 167-172.
35. immunochemistry F, Dahlstrom U. Multiple myeloma or benign monogammopathy? A study of differential diagnostic criteria. Clin Immunol Immunopathol 1978;10:168-174.
36. Knudsen LM, Hippe H, Hjorth M, Holmberg E, Westin J. Renal function in newly diagnosed multiple myeloma: A demographic study of 1353 patients. Eur J Haematol 1994;53:207-212.
37. Kyle RA, Greipp PR. Amyloidosis (AL): Clinical and laboratory features in 229 cases. Mayo Clin Proc 1983;58;665-683.
38. Belisle LM. Case DC Jr, Neveux L. Quantitation of risk of malignant transformation in patients with "benign" monoclonal gammopathy (BMG) (Abstr). Blood 1990;76(suppl 1):342a.
39. Pascali E, Pezzoli A. Serum and urine monoclonal immunoglobulins in malignant non-Hodgkin's lymphoma. Acta Haematol 1986;75:193-198.
40. Schauer PK, Straus DJ, Bagley CM Jr, et al. Angioimmunoblastic lymphadenopathy; Clinical spectrum of disease. Cancer 1981; 48:2493-2498.
41. Cheng AL, Chen YC, Su IJ, et al. Adult non-Hodgkin lymphoma in Taiwan area: A clinicopathological study of 123 cases based on working formulation classification. Taiwan-I-Hsueh-Hui-Tsa-Chih 1989;88:108-113.
42. NCI sponsored study of classifications of non-Hodgkin's lymphoma. Summary and description of a Working Formulation for Clinical Usage. The non-Hodgkin's lymphoma pathologic classification project. Cancer 1982;49:2112-2135.